Houlihan Lokey Balance Sheet Health

Financial Health criteria checks 6/6

Houlihan Lokey has a total shareholder equity of $1.8B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $3.0B and $1.2B respectively.

Key information

Debt to equity ratio

US$0

Debt

Interest coverage ratio	n/a
Cash	US$555.53m
Equity	US$1.77b
Total liabilities	US$1.19b
Total assets	US$2.96b

Recent financial health updates

No updates

Recent updates

Houlihan Lokey Q1 Earnings: Upgrading To Buy As I Gain Confidence On CY24 Recovery

Aug 05

Houlihan Lokey (NYSE:HLI) Is Increasing Its Dividend To $0.55

Jul 31

Houlihan Lokey: Fairly Valued, Now A 'Hold' (Rating Downgrade)

Jul 04

Houlihan Lokey Non-GAAP EPS of $1.14 beats by $0.02, revenue of $456M misses by $14.81M

Jan 31

Houlihan Lokey Non-GAAP EPS of $1.19 beats by $0.16, revenue of $489.54M beats by $48.12M

Oct 27

Houlihan Lokey: A Stock To Hold For The Recession And Beyond

Oct 11

Here's Why We Think Houlihan Lokey (NYSE:HLI) Might Deserve Your Attention Today

Oct 07

The Fallacy Of Inflation Protection Through Dividend Yields - Altria And Houlihan Lokey In Focus

Sep 27

Houlihan Lokey: Number One Financial Advisor, My Number One Financial Investment

Sep 07

Houlihan Lokey goes ex-dividend tomorrow

Aug 31

Houlihan Lokey Has Resilience In Sponsors And Restructuring

Jul 19

Struggling crypto lender Babel Finance reportedly employs Houlihan Lokey

Jul 01

Financial Position Analysis

Short Term Liabilities: HLI's short term assets ($945.8M) exceed its short term liabilities ($721.2M).

Long Term Liabilities: HLI's short term assets ($945.8M) exceed its long term liabilities ($468.4M).

Debt to Equity History and Analysis

Debt Level: HLI is debt free.

Reducing Debt: HLI has no debt compared to 5 years ago when its debt to equity ratio was 1.1%.

Debt Coverage: HLI has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: HLI has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Houlihan Lokey Balance Sheet Health

Financial Health criteria checks 6/6

Key information

Recent financial health updates

Recent updates

Investors Interested In Houlihan Lokey, Inc.'s (NYSE:HLI) Earnings

Houlihan Lokey, Inc. Appoints Ashish Patel as Managing Director in Its Capital Markets Group

Houlihan Lokey, Inc Announces Management Appointments

Houlihan Lokey, Inc. Appoints Abhishek Jain as a Managing Director in its Transaction Advisory Services Practice

Houlihan Lokey, Inc. Appoints Val Shapiro to its Financial Sponsors Group as Managing Director

Brent Shepherd Joins as Managing Director in its Capital Markets Group of Houlihan Lokey, Inc

Houlihan Lokey, Inc. Announces Chief Executive Officer Changes

Upcoming dividend of US$0.55 per share

Third quarter dividend of US$0.55 announced

Third quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Houlihan Lokey: Current Rate Environment Is Positive

Houlihan Lokey, Inc. Declares A Regular Quarterly Cash Dividend of Class A and Class B Common Stock, Payable on March 15, 2024

Houlihan Lokey: Limited Upside Due To High Valuation

Houlihan Lokey, Inc. Appoints Michael Hommeyer as Managing Director in Its Capital Markets Group

Houlihan Lokey, Inc. to Report Q3, 2024 Results on Feb 01, 2024

Price target increased by 8.8% to US$121

Houlihan Lokey, Inc. Expands Healthcare Group with Two Senior Hires

Getting In Cheap On Houlihan Lokey, Inc. (NYSE:HLI) Is Unlikely

Executive Chairman notifies of intention to sell stock

Houlihan Lokey, Inc. (NYSE:HLI) signed a definitive agreement to acquire Triago Management Development S.A.R.L.

Houlihan Lokey, Inc. (NYSE:HLI) signed a definitive agreement to acquire Triago Management Development S.A.R.L.

Houlihan Lokey, Inc. Announces Management Changes

Houlihan Lokey, Inc. Appoints Rob Kordas as Managing Director in Its Industrials Group

MD & CFO exercised options and sold US$1.1m worth of stock

Upcoming dividend of US$0.55 per share at 2.1% yield

Houlihan Lokey, Inc. Appoints Kartik Sudeep as A Managing Director to Financial Technology Group

CEO & Director notifies of intention to sell stock

Houlihan Reportedly in Talks to Acquire Triago

Houlihan Lokey: Recovery Is On The Right Track

Houlihan Lokey, Inc. Declares Quarterly Cash Dividend on Class A and Class B Common Stock, Payable on December 15, 2023

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Houlihan Lokey, Inc. to Report Q2, 2024 Results on Oct 26, 2023

Houlihan Lokey: It Can Gain From Economy's Pain

Houlihan Lokey, Inc. Announces Appointment of Julia Perroni as Managing Director in its Capital Markets Group

Houlihan Lokey Launches Sustainability Advisory Services Practice

Houlihan Lokey (NYSE:HLI) Is Paying Out A Larger Dividend Than Last Year

Upcoming dividend of US$0.55 per share at 2.2% yield

Houlihan Lokey Q1 Earnings: Upgrading To Buy As I Gain Confidence On CY24 Recovery

Houlihan Lokey (NYSE:HLI) Is Increasing Its Dividend To $0.55

Houlihan Lokey, Inc., Annual General Meeting, Sep 20, 2023

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Houlihan Lokey, Inc. Declares Regular Quarterly Cash Dividend of Class A and Class B Common Stock, Payable on September 15, 2023

Houlihan Lokey, Inc. Appoints Jonathan Jameson as Managing Director of Private Funds Group

Price target increased by 10% to US$103

Houlihan Lokey, Inc. to Report Q1, 2024 Results on Jul 27, 2023

Houlihan Lokey, Inc. (NYSE:HLI) entered into an agreement to acquire 7 Mile Advisors, LLC.

Houlihan Lokey: Fairly Valued, Now A 'Hold' (Rating Downgrade)

Houlihan Lokey, Inc.(NYSE:HLI) dropped from Russell 2000 Growth-Defensive Index

Executive Chairman notifies of intention to sell stock

Upcoming dividend of US$0.55 per share at 2.5% yield

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of US$0.53 per share at 2.2% yield

Houlihan Lokey Appoints Daniel East as Managing Director

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Houlihan Lokey Declares A Regular Quarterly Cash Dividend Payable on March 15, 2023

Houlihan Lokey Non-GAAP EPS of $1.14 beats by $0.02, revenue of $456M misses by $14.81M

Houlihan Lokey, Inc. to Report Q3, 2023 Results on Jan 31, 2023

Consensus EPS estimates fall by 12%

Now 21% undervalued

Executive Chairman exercised options and sold US$1.5m worth of stock

Upcoming dividend of US$0.53 per share

High number of new directors

Houlihan Lokey, Inc. (NYSE:HLI) agreed to acquire Oakley Advisory Limited.

CEO & Director exercised options and sold US$1.5m worth of stock

Houlihan Lokey Appoints Matthew Hudson and Spencer Lippman as Managing Directors

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Houlihan Lokey, Inc. Declares Quarterly Cash Dividend, Payable on December 15, 2022

Houlihan Lokey Non-GAAP EPS of $1.19 beats by $0.16, revenue of $489.54M beats by $48.12M

Houlihan Lokey Appoints Andy Cairns as Managing Director and Head of Middle East and Africa, Capital Markets, Based in Dubai

Houlihan Lokey Announces Rainer Hepberger Joins Firm as A Managing Director in Its European Healthcare Team

Houlihan Lokey, Inc. to Report Q2, 2023 Results on Oct 27, 2022

Houlihan Lokey: A Stock To Hold For The Recession And Beyond

Houlihan Lokey, Inc. Appoints Keith Skirbe as A Managing Director

Here's Why We Think Houlihan Lokey (NYSE:HLI) Might Deserve Your Attention Today

High number of new directors